JPRN-jRCT1050200031Not yet recruiting未知
Registry for sweating function in atopic dermatitis patients - ADSF Registry
Fukunaga Atsushi0 sites85 target enrollmentStarted: June 26, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 85
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- >= 18age old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- •Patients with atopic dermatitis and Healthy control aged 18 years or older who are hospitalized or are in hospital at Kobe University Hospital, Hiroshima University Hospital, Kawasaki Medical School Hospital, and Nagasaki University Hospital.
Exclusion Criteria
- •Patients who have at least one of the following are excluded.
- •1. Patients who have difficulty performing a sweat test by Impression mold (IM) method
- •2. Pregnant and lactating patients
- •3. Patients under the age of 18
- •4. Patients who are considered unsuitable by the study personnel
Investigators
Similar Trials
Completed
Not Applicable
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trialAtopic dermatitisJPRN-UMIN000041204Takashima Clinic57
Completed
Not Applicable
Study of genetic and protein markers that influence Atopic Dermatitis diseaseCTRI/2019/04/018554Strand Life Sciences Pvt Ltd12
Recruiting
Phase 3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisAtopic DermatitisNCT06461897AbbVie675
Active, not recruiting
Phase 1
Emollients in the management of atopic dermatitis in children: prevention of flares.MedDRA version: 14.1 Level: LLT Classification code 10003639 Term: Atopic dermatitis System Organ Class: 100000004858Atopic dermatitisEUCTR2012-004621-24-PLPIERRE FABRE MEDICAMENT347
Active, not recruiting
Not Applicable
Emollients in the management of atopic dermatitis in chidren: prevention of flares.Atopic dermatitisEUCTR2012-004621-24-LTPIERRE FABRE MEDICAMENT409